Formulation Services

Our early-phase formulation development services help solve oral bioavailability challenges encountered at both preclinical formulation development and clinical formulation development stages. We can address following issues through in-depth solubilization and enabling various technologies:

• Incomplete dissolution
• Low solubility
• Low oral bioavailability

Our services for discovery phase formulation development are tailored to address specific challenges which arise due to:

• Higher systemic exposure requirements for toxicology studies
• Non-feasibility of high doses or strengths
• Studies in varied animal species
• Emesis
• Compound limitation
• Liquid dosage form requirement
• Precipitation of compound at absorption site

We offer formulation development services from GLP-compliant and cGMP environment to meet client requirements. Our formulation development services can help in translating new drug candidates into drug products for your clinical trial needs.

Our formulation development services include:

• Preclinical (Oral- Solution, suspensions and microdose capsules, Parenterals- aqueous liquid injectables, non-aqueous injectables, lyophilized injectables, ophthalmic and otic solutions and nasal solutions)
• First in human formulations (Oral Solids, Parenterals)
• Clinical formulations (Oral solids, soft gelatin capsules and parenterals-aqueous liquid injectables, non-aqueous injectables, lyophilized injectables, ophthalmic and otic solutions and nasal solutions)

We conduct all characterization studies in-house. Dissolution testing is a requirement for solid oral dosage forms throughout the development life cycle and commercial manufacturing. Our services help understand the process in which a substance forms a solution and measure the extent and rate of solution formation from a dosage form, such as a tablet, capsule, and ointment.

Our characterization services for NCEs, generics and first generics help assess the quality characteristics of drug products such as physical and chemical properties, which are primary elements to ensure the desired quality, considering the safety and efficacy of the drug product.

We help to understand physical, chemical, biological, and microbiological properties or characteristics that should be within an appropriate specification to ensure the desired product quality.

The potential physical and chemical interactions between drugs and excipients can affect the dosage form's chemical, physical, and therapeutic properties, and stability. Drug excipient compatibility studies are an important part of understanding the role of inactive ingredients (excipients) in product quality and performance. Our mechanistic understanding of the drug substance and its impurities, excipients, and impurities, degradation pathway, and potential processing conditions helps select the right excipients for the compatibility study.

We help our clients understand the stability and quality of drug substances (API) and drug products (finished formulation) against different environmental factors such as temperature, humidity, and light. Our stability testing services are offered by ICH guidelines. They include the study of product-related factors that influence the quality of a drug, such as the interaction of an API with excipients, container closure systems, and packaging materials but also the proneness to oxidation and hydrolysis.

We manufacture clinical formulations from our USFDA-inspected sites based out of Hyderabad and Visakhapatnam, India. We can cater to manufacture oral solids as well as soft gelatin formulations.